We report the case of a 49-year-old man who experienced dry cough and itching eruption for 2 months. The patient had Gottoron's sign, mechanic's hand, and high levels of serum Krebs von den Lungen-6 and surfactant protein D, but was negative for anti-aminoacyl transfer RNA synthetase antibodies. High-resolution chest computed tomography revealed subpleural band-like or patchy consolidation with predominance in the bilateral lower lobe. Bronchoalveolar lavage fluid showed increased total cell counts with lymphocytosis. Video-assisted thoracic surgery specimens were consistent with fibrocellular non-specific interstitial pneumonia (NSIP) accompanied by accumulation of lymph follicles within fibrosis. After combination therapy with prednisolone and cyclosporin A, his clinical symptoms improved gradually. Finally, an anti-melanoma differentiationassociated gene 5 (anti-MDA5) antibody was detected. No relapse of the disease has been observed for 2 years. This is the first reported case in which anti-MDA5 antibody-positive clinically amyopathic dermatomyositis associated with fibrocellular NSIP characterized by subacute onset was found to have favourable prognosis.
Introduction
Clinically amyopathic dermatomyositis (CADM) describes a condition characterised by skin rash typically associated with dermatomyositis but without muscle involvement such as muscle weakness and an increased serum creatinine phosphokinase and aldolase values, in a subgroup of patients [1] . Anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody-positive DM is a new variant of CADM that presents with characteristic mucocutaneous findings and is associated with a higher risk of developing rapidly progressive interstitial lung disease (RP-ILD), which has a high mortality rate [2] . Although some researchers have reported RP-ILD associated with anti-MDA5 antibody-positive CADM, little information is available on the clinical characteristics of subacute onset with favourable prognosis.
Case Report
We report the case of a 49-year-old man who had experienced dry cough and itching eruption for over 2 months. He had a smoking history of five cigarettes per day for 15 years. The patient had Gottoron's sign, mechanic's hand, dermatitis seborrhoeic-like erythema with desquamation on the face and poikiloderma on the neck, abdomen, and back. Laboratory data on admission showed high levels of serum Krebs von den Lungen-6 (KL-6) (703 U/mL), ferritin (425 ng/mL) and creatine kinase (54 IU/L) and was negative for anti-aminoacyl transfer RNA synthetase antibodies. Results of arterial blood gas analysis were pH 7.432; partial pressure of carbon dioxide (PaCO 2 ) 34.9 Torr; and partial pressure of oxygen (PaO 2 ) 113.0 Torr on room air. The pulmonary function test revealed normal range of spirometry (vital capacity (VC) 4.91 L, 124.3% of predicted) with decreased diffusing capacity for carbon monoxide (DLco 9.63 mL/min/mm Hg, 25.1% of predicted). High-resolution chest computed tomography revealed band-like and patchy consolidation with subpleural sparing on the bilateral lower lobes ( Fig. 1A and B) . Examination of bronchoalveolar lavage (BAL) fluid showed an increased total cell count of 1.41 × 105/mL and elevated lymphocytosis (lymphocytes 63.0%; neutrophils 7.0%; and macrophages 30.0%) and a normal CD4/CD8 ratio of 1.89. The lung biopsy specimens of the right segments S9 and S10 obtained by videoassisted thoracic surgery (VATS) showed fibrocellular nonspecific interstitial pneumonia (NSIP) accompanied by accumulation of lymph follicle formation (Fig. 1C-E) . Consequently, the patient was diagnosed as having fibrocellular NSIP associated with CADM. We started combination therapy with prednisolone (PSL) (60 mg/day) and cyclosporin A (CyA) (100 mg). After these initial treatments, the patient's skin symptoms resolved and serum ferritin and KL-6 levels gradually reduced. In addition, chest abnormalities in both lungs resolved immediately. As an anti-MDA5 antibody was detected at this point, we made a final diagnosis of CADM with MDA5 antibodypositive. Corticosteroid was tapered during follow-up observation. No relapse has been observed for 2 years after initial treatments (Fig. 2) .
Discussion
CADM is a relatively rare phenotype of DM, and it has been reported recently that anti-MDA5 antibodies could be useful for the diagnosis of CADM [1] . Patients with anti-MDA5 antibody-positive DM are more likely to have mild or absent muscle involvement and a higher risk of developing fatal RP-ILD than patients with classical DM [2] . As described by Tanizawa et al. [3] , the lower peripheral or peribronchovascular consolidation pattern and the presence of anti-MDA5 antibodies were independent predictors of 90-day mortality in patients with polymyositis and DM-ILD. In addition, Gono et al. [4] reported that a serum level of ferritin >1500 ng/mL indicates a poor prognosis in patients with DM associated with RP-ILD. Although refractory anti-MDA5 antibody-positive CADM associated with RP-ILD has been well described [2] , some patients had subacute onset and favourable prognosis like the present case. Indeed, despite the presence of anti-MDA5 antibodies and lower peripheral or peribronchovascular consolidation pattern, the patient had several favourable factors such as normal levels of PaO 2 , %VC, and ferritin. Therefore, combination therapy with PSL without pulse therapy and CyA was extremely effective in the present case. With regard to the treatments for RP-ILD associated with anti-MDA5 antibody-positive CADM, even though a variety of combination therapies with high-dose corticosteroid and immunosuppressants such as intravenous cyclophosphamide, CyA, tacrolimus, and azathioprine were administered, there have been less satisfying responses so far. On the other hand, there are several histopathological patterns in CADM-ILD. Fujisawa et al. [5] reported that histopathological findings in surgical lung biopsy and autopsy cases of CADM-ILD were NSIP in 12 cases, usual interstitial pneumonia in two cases, and diffuse alveolar damage in five cases. However, the most common histological pattern in CADM with MDA5 antibody-positive remained unclear. In the present case, the lung biopsy specimens obtained by VATS showed fibrocellular NSIP accompanied by accumulation of lymph follicle formation. These findings may imply connective tissue disease-ILD and degree of response to corticosteroids and/or immunosuppressant agents. Overall, our patient remained clinically stable for 2 years from the initial visit. We believe that subacute onset and histopathological fibrocellular NSIP pattern could affect the patient's outcome. In other words, clinical characteristics and histological pattern of interstitial pneumonia can be useful information in deciding the treatment method and prognosis. This is the first reported case in which anti-MDA5 antibody-positive CADM associated with fibrocellular NSIP characterized by subacute onset has been shown to have favourable prognosis and recovery without multimodality therapy such as corticosteroid and/or cyclophosphamide pulse therapy.
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